Latest filing published 23 Apr 2025 for AIM ImmunoTech Inc., €4,441. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William M. Mitchell discloses dealings in AIM ImmunoTech Inc. to SEC (Form 4). We count 13 filings; the first trade dates from 2 December 2024 and the latest from 11 April 2025.
Market trades split into 1 purchase (€4,441) and 1 sale (€854). On balance, insiders were net buyers of €3,587. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 11 share grants. In 2025 alone, the filings show 1 purchase and no sales.
Most recently, on 23 April 2025, the filings show an open-market purchase worth €4,441 in AIM ImmunoTech Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations